Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Gene Therapy Focus

Explore the latest updates and expert interviews
Latest Videos Videos by Disease CAR-T Therapy Conferences Features Podcasts

Welcome to the Gene Therapy Focus

Explore the latest in this field by hematological disease type, showcasing expert interviews and discussions, podcasts and more.

The Gene Therapy Channel covers a variety of therapy types, with a focus on CAR-T therapy and other genome-editing techniques, including CRISPR-Cas9.

Videos by Disease

Multiple Myeloma
Lymphoma
Non-Malignant
AML
CLL
ALL
2:11
Promising approaches being explored in high-risk myeloma & trials to look out for
Sham Mailankody • 24 Oct 2025
2:35
How is the definition of high-risk myeloma evolving in the era of CAR T-cell therapy?
Sham Mailankody • 24 Oct 2025
3:13
Innovative approaches to trial design in high-risk myeloma & how these may improve data collection
Sham Mailankody • 24 Oct 2025
1:30
The future of in vivo CAR T-cell therapy
Karlo Perica • 24 Oct 2025
View All Videos
1:24
The efficacy of glofitamab in patients with heavily pre-treated R/R MCL
Tycel Phillips • 5 Sep 2025
0:48
Durability of responses in patients with DLBCL treated with liso-cel: real-world insights
Krish Patel • 4 Sep 2025
1:52
Bispecifics and CAR T-cell therapy in lymphoma: sequencing strategies and considerations
Tycel Phillips • 5 Sep 2025
32:58
Advances in MCL treatment: insights from TRIANGLE, the changing role of SCT & novel targeted agents
Georg Hesset al. • 20 Oct 2025
View All Videos
10:55
Transplantation and gene therapy in SCD and thalassemia: donor types and indications
Subarna Chakravorty • 3 Nov 2025
3:27
What may the future hold for the treatment of sickle cell disease?
Enrico Novelli • 15 Oct 2025
2:23
Key trials of interest in the thalassemia space
Maria Dimopoulou • 20 Oct 2025
4:24
Proof-of-concept: using epigenome editing in SCD and beta-thalassemia
Letizia Fontana • 16 Oct 2025
View All Videos
16:15
Approaching TP53-mutated AML: current challenges, ongoing research & novel therapeutic strategies
Andrew Weiet al. • 19 Sep 2025
1:25
Perspectives on the promise and challenges of NK cell therapies in AML
John DiPersio • 19 Sep 2025
17:15
Immunotherapy in AML: translational insights and promising avenues being explored
Ann-Kathrin Eisfeldet al. • 20 Sep 2025
1:51
Immune-based strategies in AML: current limitations and novel targets being explored
David Sallman • 4 Sep 2025
View All Videos
2:40
A real-world analysis of CNS involvement in CLL
Jacob Soumerai • 18 Sep 2025
1:35
Novel therapies and clinical trial approaches for Richter’s transformation
Catherine Coombs • 9 Sep 2025
4:03
Interim analysis of GIMEMA CLL2020: impact of ibrutinib/venetoclax on CAR T-cell generation in CLL
Marta Coscia • 13 Sep 2025
1:09
Strategies being explored to enhance the metabolic function of T-cells in CLL
Helga Simon-Molas • 13 Sep 2025
View All Videos
1:38
How the role of alloSCT has evolved in ALL with the introduction of novel agents
Alexandra Gomez-Arteaga • 11 Sep 2025
2:11
Moving next-generation CAR constructs into ALL therapy
Bijal Shah • 4 Sep 2025
1:44
The potential value of early integration of CAR-T in ALL
Bijal Shah • 4 Sep 2025
1:15
Exploring strategies to optimize post-CAR-T outcomes in patients with ALL
Bijal Shah • 4 Sep 2025
View All Videos

Conferences

IMS 2025
iwCLL 2025
SOHO 2025
ICML 2025
EHA 2025
EBMT 2025
3:58
The impact of intensive chemotherapy-based bridging on outcomes of CAR-T therapy in multiple myeloma
Rahul Banerjee • 19 Sep 2025
2:14
Updates on current research exploring treatment strategies for high-risk smoldering myeloma
Karthik Ramasamy • 15 Sep 2025
2:01
Genomic drivers of resistance to anti-BCMA immunotherapies in multiple myeloma
Francesco Maura • 19 Sep 2025
1:15
Advances in immunotherapy for multiple myeloma: CAR-T, bispecifics, and trispecifics
Charlotte Pawlyn • 19 Sep 2025
View All Videos
2:40
A real-world analysis of CNS involvement in CLL
Jacob Soumerai • 18 Sep 2025
4:03
Interim analysis of GIMEMA CLL2020: impact of ibrutinib/venetoclax on CAR T-cell generation in CLL
Marta Coscia • 13 Sep 2025
1:09
Strategies being explored to enhance the metabolic function of T-cells in CLL
Helga Simon-Molas • 13 Sep 2025
1:20
A tandem CD19/ROR1 CAR-NK to overcome apoptotic resistance in CLL
Matthew Davids • 13 Sep 2025
View All Videos
1:38
How the role of alloSCT has evolved in ALL with the introduction of novel agents
Alexandra Gomez-Arteaga • 11 Sep 2025
4:02
How AI and digital innovation are transforming transplant care
Amin Turki • 5 Sep 2025
1:55
Bridging the gap in myeloma care: ensuring access for all patients
Joseph Mikhael • 5 Sep 2025
1:41
Promising targets in multiple myeloma: BCMA, GPRC5D, and FcRH5
Yi Lin • 4 Sep 2025
View All Videos
3:36
The use of BOOM-BOOM radiation prior to liso-cel in aggressive B-cell non-Hodgkin lymphoma
Christopher D'Angelo • 13 Jun 2025
2:55
The efficacy & toxicity of radiation therapy prior to CAR T-cell therapy in R/R myeloma
Kathryn Tringale • 12 Jun 2025
1:45
Moving away from chemotherapy-based approaches in R/R DLBCL: the impact of immunotherapies
Adam Olszewski • 18 Jun 2025
1:01
CAR T-cell therapy in vitreoretinal lymphoma: challenges and upcoming trials in this space
Sylvain Choquet • 20 Jun 2025
View All Videos
1:45
The impact of extramedullary disease on outcomes of CAR T-cell therapy in multiple myeloma
Shambavi Richard • 13 Jun 2025
2:41
Exciting developments in the myeloma space: CAR T-cells and bispecific antibodies
Yi Lin • 13 Jun 2025
2:14
The key unmet needs in the management of cellular therapy-related toxicities
Kai Rejeski • 12 Jun 2025
1:12
Short-term patient-reported adverse events & HRQoL by CAR-T product in aggressive B-cell lymphomas
Fabio Efficace • 14 Jun 2025
View All Videos
2:06
The CAR FACTORY network: developing genetically optimized CAR-T and CAR-NK cellular therapies
Evelyn Ullrich • 11 Apr 2025
3:49
Tackling the challenges with generating “off-the-shelf” allogeneic T-cell & NK-cell products
Rizwan Romee • 4 May 2025
3:47
The risk of myelopathy following CAR-T and managing this rare complication
Parastoo Dahi • 22 Apr 2025
5:44
The risk of developing leukemia after lentiviral gene therapy
Akshay Sharma • 9 Apr 2025
View All Videos
The content of VJHemOnc is intended for healthcare professionals